Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 345

Similar articles for PubMed (Select 17164307)

1.

Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.

Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM; AIDS Clinical Trials Group Protocol A5079 Study Team.

J Clin Endocrinol Metab. 2007 Mar;92(3):1049-57. Epub 2006 Dec 12.

PMID:
17164307
2.

Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.

Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, Marsolais C, Turner R, Grinspoon S.

J Clin Endocrinol Metab. 2010 Sep;95(9):4291-304. doi: 10.1210/jc.2010-0490. Epub 2010 Jun 16.

PMID:
20554713
3.

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.

Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G.

J Clin Endocrinol Metab. 1998 Sep;83(9):3155-62.

PMID:
9745419
4.

Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.

Hoyos CM, Yee BJ, Phillips CL, Machan EA, Grunstein RR, Liu PY.

Eur J Endocrinol. 2012 Oct;167(4):531-41. doi: 10.1530/EJE-12-0525. Epub 2012 Jul 30.

5.

Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.

J Clin Endocrinol Metab. 2000 Jan;85(1):35-41.

PMID:
10634360
6.

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI.

J Clin Endocrinol Metab. 2008 Jan;93(1):139-46. Epub 2007 Oct 16.

PMID:
17940111
7.

Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.

Lovejoy JC, Bray GA, Greeson CS, Klemperer M, Morris J, Partington C, Tulley R.

Int J Obes Relat Metab Disord. 1995 Sep;19(9):614-24.

PMID:
8574271
8.

Effects of androgen therapy on adipose tissue and metabolism in older men.

Schroeder ET, Zheng L, Ong MD, Martinez C, Flores C, Stewart Y, Azen C, Sattler FR.

J Clin Endocrinol Metab. 2004 Oct;89(10):4863-72.

PMID:
15472177
9.

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.

Ann Intern Med. 1998 Jul 1;129(1):18-26.

PMID:
9652995
10.

Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.

Bredella MA, Gerweck AV, Lin E, Landa MG, Torriani M, Schoenfeld DA, Hemphill LC, Miller KK.

J Clin Endocrinol Metab. 2013 Sep;98(9):3864-72. doi: 10.1210/jc.2013-2063. Epub 2013 Jul 3.

11.

Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.

Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M.

J Clin Endocrinol Metab. 2010 Sep;95(9):4361-6. doi: 10.1210/jc.2009-2502. Epub 2010 Jul 7.

12.

Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.

Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S.

JAMA. 2008 Aug 6;300(5):509-19. doi: 10.1001/jama.300.5.509.

14.

Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.

Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT.

JAMA. 2008 Jan 2;299(1):39-52. doi: 10.1001/jama.2007.51. Erratum in: JAMA. 2008 Feb 13;299(6):634.

PMID:
18167405
15.

Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.

Koutkia P, Canavan B, Breu J, Torriani M, Kissko J, Grinspoon S.

JAMA. 2004 Jul 14;292(2):210-8.

PMID:
15249570
16.

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.

J Clin Endocrinol Metab. 2000 Aug;85(8):2767-74.

PMID:
10946879
17.

Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

Bredella MA, Lin E, Brick DJ, Gerweck AV, Harrington LM, Torriani M, Thomas BJ, Schoenfeld DA, Breggia A, Rosen CJ, Hemphill LC, Wu Z, Rifai N, Utz AL, Miller KK.

Eur J Endocrinol. 2012 Apr;166(4):601-11. doi: 10.1530/EJE-11-1068. Epub 2012 Jan 24.

18.

The metabolic effects of preferential reduction of visceral adipose tissue in abdominally obese men.

Marks SJ, Chin S, Strauss BJ.

Int J Obes Relat Metab Disord. 1998 Sep;22(9):893-8.

PMID:
9756248
19.

Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.

Sutinen J, Walker UA, Sevastianova K, Klinker H, Häkkinen AM, Ristola M, Yki-Järvinen H.

Antivir Ther. 2007;12(1):97-105.

PMID:
17503753
20.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk